Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
JAGUAR LAND ROVER's chief executive has left open the possibility of building cars in the US as questions remain about the newly announced UK-US trade agreement, reported the Telegraph.
Adrian Mardell said that while there are no immediate plans to shift manufacturing across the Atlantic, he couldn't dismiss the idea completely given the ongoing trade uncertainties.
"We had and currently have no cause to build cars in the US at this time, but we cannot discount that it could be the case at some point," Mardell was quoted as saying.
His comments will worry government officials who are rushing to finalise practical aspects of the trade deal announced last week by prime minister Sir Keir Starmer and US president Donald Trump.
The agreement has reduced tariffs from a potential 27.5 per cent down to 10 per cent for the first 100,000 vehicles exported from the UK to the US. This has already prompted JLR to restart US shipments after previously pausing them.
JLR, owned by India's Tata Motors, currently manufactures its popular Range Rovers in Solihull, West Midlands, while producing models like the Land Rover Discovery and Defender elsewhere in Europe.
North America represents a crucial market for the luxury carmaker, with 129,000 vehicles sold there in the year ending March — roughly a third of its worldwide sales. Most of these sales occurred in the US.
However, car manufacturers are still awaiting key details about how the agreement will work in practice. Bentley's chief executive Frank-Steffen Walliser expressed concerns at a Financial Times conference about the current uncertainty.
"The worst thing that can happen to a running business is the announcement of lower tariff," Walliser explained. "It means all your customers say 'I won't buy a car now', especially our customers, our clients don't need a car at the moment."
He added that the lack of clarity was seriously affecting business: "It is super hard on the business at the moment, nobody's moving."
One major question remains about how the tariff-free quota of 100,000 vehicles will be divided among different car companies.
"Is the 100,000 for Bentley? I can live with that," Walliser remarked. "But I assume our colleagues from JLR would also like to have a chunk."
Bentley, which sells around 4,000 cars annually in the Americas with the US being its largest market, has so far avoided price increases by shipping vehicles to America before tariffs were imposed. However, Walliser warned this strategy was becoming unsustainable as stock levels decreased.
"Don't get me wrong, I'm not complaining," he said about the trade deal. "But it is not operational."
Despite these concerns, Starmer has defended the agreement, insisting it "delivers for British business and British workers protecting thousands of British jobs in key sectors including car manufacturing and steel."
OpenAI is facing legal challenges in India, with publishers and news outlets accusing it of using their content without permission to train ChatGPT. (Photo: Reuters)
OPENAI, the company behind ChatGPT, will open its first India office in New Delhi later this year as it expands in its second-largest market by user numbers.
The Microsoft-backed firm has been registered as a legal entity in India and has started hiring for a local team, the company said in a statement shared with Reuters on Friday.
India is a key market for ChatGPT, which launched its lowest-priced monthly plan at $4.60 earlier this week. The move aims at reaching nearly one billion internet users in the country.
OpenAI is facing legal challenges in India, with publishers and news outlets accusing it of using their content without permission to train ChatGPT. The company has denied these claims.
"Opening our first office and building a local team is an important first step in our commitment to make advanced AI more accessible across the country and to build AI for India, and with India," OpenAI CEO Sam Altman said in the statement.
Competition in India is intensifying, with Google’s Gemini and AI startup Perplexity offering plans that give many users free access to advanced features.
India has the largest student user base for ChatGPT, and weekly active users have quadrupled in the past year, according to market data shared by OpenAI on Friday.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
White House senior counselor for trade and manufacturing Peter Navarro speaks to reporters outside of the West Wing of the White House on August 21, 2025. (Photo: Getty Images)
WHITE HOUSE trade adviser Peter Navarro criticised India as being a "Maharaj" in tariffs and claimed it operated a "profiteering scheme" by using discounted Russian crude oil, as a war of words between India and the US continued to escalate.
Navarro's comments came as India’s foreign minister, S Jaishankar, said the US had asked New Delhi to help stabilise global energy markets by buying Russian oil.
India was "cosying up to" Chinese president Xi Jinping, Navarro added.
Meanwhile, China’s ambassador to India, Xu Feihong, said Beijing "firmly opposes" Washington's steep tariffs on Delhi and called for greater co-operation between India and China, BBC reported.
According to the broadcaster, Xu likened the US to a "bully" and blamed Washington for benefiting from free trade.
However, the US was now using tariffs as a "bargaining chip" to demand "exorbitant prices" from other nations, the Chinese diplomat was quoted as saying.
Relations between New Delhi and Washington have become strained after US president Donald Trump doubled tariffs on Indian goods to 50 per cent, including a 25 per cent additional duties for India's purchase of Russian crude oil.
Navarro told reporters in the US, “Prior to Russia's invasion of Ukraine in February 2022, India virtually bought no Russian oil... It was like almost one per cent of their need. The percentage has now gone up to 35 per cent.”
Earlier this week, Navarro wrote in the Financial Times criticising India for its procurement of Russian crude oil.
He dismissed the argument that India needs Russian oil to meet its energy requirement, saying the country acquired cheap Russian oil before making refined products, then sold on at premium prices in Europe, Africa and Asia.
"It is purely profiteering by the Indian refining industry," Navarro said.
"What is the net impact on Americans because of our trade with India? They are Maharaj in tariff. (We have) higher non-tariff barriers, massive trade deficit etc - and that hurts American workers and American business," according to him.
“The money they get from us, they use it to buy Russian oil which then is processed by their refiners,” he added.
"The Russians use the money to build arms and kill Ukrainians and Americans tax-payers have to provide more aid and military hardware to Ukrainians. That's insane.
"India does not want to recognise its role in the bloodshed," Navarro said.
Though the US imposed an additional 25 per cent tariff on India for its energy ties with Russia, it has not initiated similar actions against China, the largest buyer of Russian crude oil.
Defending its purchase of Russian crude oil, India has maintained that its energy procurement is driven by national interest and market dynamics.
India turned to purchasing Russian oil sold at a discount after Western countries imposed sanctions on Moscow and shunned its supplies over its invasion of Ukraine in February 2022.
Consequently, from a 1.7 per cent share in total oil imports in 2019-20, Russia's share increased to 35.1 per cent in 2024-25, and it is now the biggest oil supplier to India.
Tesco has increased the price of its meal deal, sparking shopper anger.
Clubcard members now pay £3.85 (up from £3.60), while non-members pay £4.25 (up from £4).
Premium meal deals also rise, costing up to £6 without a Clubcard.
Some shoppers threaten a boycott, while others argue the deal still offers value.
Tesco raises meal deal prices
Tesco has announced a price hike on its popular meal deals, prompting criticism from shoppers and even boycott threats.
From this week, the standard meal deal — which includes a main such as a sandwich or salad, a snack, and a drink — will cost £3.85 for Clubcard holders (up from £3.60), and £4.25 for non-Clubcard holders (up from £4).
The supermarket’s premium meal deal, which includes higher-end options, has also gone up from £5 to £5.50 for Clubcard holders, and from £5.50 to £6 for those without.
Shopper reactions divided
The price rise has sparked a wave of frustration online, with some customers claiming the deal no longer offers value.
On Reddit, one shopper wrote: “I will be boycotting the meal deal from [Tesco] when this hike occurs.” Another added: “That’s it, I’m legit done buying these now.”
A reader responding to Manchester Evening News said: “Everything that once was a deal no longer is.”
However, not all shoppers share the outrage. Marlene Whitehead commented: “That’s still good value.” While Peter Collins argued: “It’s actually still very good value compared to buying the items separately eg., Costa coffee on its own would be roughly £2.60.”
Do Tesco meal deals still save money?
Despite the increase, Tesco insists its meal deal remains competitive. Popular choices — such as a Tesco Chicken Club sandwich, an Egg Protein Pot, and a 500ml Coca-Cola — cost £6.50 if bought individually.
That means Clubcard members still save £2.65, while non-members save £2.25.
Keep ReadingShow less
Looking ahead, Chaudry said: 'Our core strategy is centred on gyms, fitness, and wellness. Through our premium health club brand M Club and our affordable fitness chain igym, we will continue expanding across the UK.'
WATERWORLD Aqua Park has been sold to European leisure operator the Looping Group in a multi-million pound deal.
The sale takes M Investment Group’s net assets beyond £110 million, with overall shareholder value now exceeding £170 million.
Mo Chaudry, chairman of M Investment Group, said: “Waterworld has been a huge part of my life and business journey and I am proud of everything we have achieved as a Team. I am now handing over the baton to Looping, a world-class operator with the vision and expertise to take Waterworld even further ensuring the resort has an exciting future.”
He said Waterworld had been “an incredible success story and a big part of my life for over 26 years. But the time is right to hand over the baton to Looping, a world-class operator with the scale and expertise to take the attraction to the next level. This sale also enables M Investment Group to sharpen our focus on our core strengths in fitness, wellness, and international leisure opportunities.”
Chaudry confirmed that the details of the deal remain confidential but added: “As a result, M Investment Group’s net assets now exceed £110 million, and our overall business worth has grown to more than £170 million. It’s a major milestone in our journey.”
He said staff jobs at Waterworld are secure. “They have a proven track record of running successful leisure destinations across Europe, and they’ve made a clear commitment to investing in the park and supporting the local community. Staff jobs are secure, and the park’s loyal visitors can expect even more exciting developments ahead.”
Looking ahead, Chaudry said: “Our core strategy is centred on gyms, fitness, and wellness. Through our premium health club brand M Club and our affordable fitness chain igym, we will continue expanding across the UK. At the same time, our fitness solutions provider Pulse Global Group is targeting strong international growth in the Middle and Far East regions with outstanding long-term potential.”
He said Waterworld had played a key role in his business journey. “Waterworld has been more than just a business — it’s been a passion. It taught me valuable lessons in entrepreneurship, resilience, and vision. It’s been a place where millions of families have created memories, and I’m proud to have played a part in that.”
Chaudry confirmed he will not remain involved in its operations. “Waterworld will now be fully operated by Looping. I’ll remain a passionate supporter but my focus as Chairman of M Investment Group will be on driving our next phase of growth.”
Looping Group operates more than 20 leisure destinations across Europe. Laurent Bruloy, Executive Chairman and co-founder of the group, said: “We are delighted to welcome Waterworld into the Looping family. It is a truly iconic attraction, and we look forward to building on its reputation for excellence while supporting the regional community.”
Chaudry said he is now focused on the future. “I’m excited about the opportunity to make a lasting impact on health and wellbeing, both in the UK and internationally. With the combined strength of M Club, igym, and Pulse Global Group, we are well positioned in the fast-growing fitness and wellness sector whilst continuing to build a world-class family investment group.”
Keep ReadingShow less
FILE PHOTO: A pharmacist shows a box of Prednisolone by Zentiva in Brest, western France. -(FRED TANNEAU/AFP via Getty Images)
INDIA's Aurobindo Pharma on Wednesday (20) dismissed media reports suggesting it had finalised a deal to acquire Czech drugmaker Zentiva, calling the claims “premature” and added that no binding agreement has been signed.
The clarification came after The Economic Times reported that Aurobindo was the frontrunner to acquire Zentiva from US-based private equity firm Advent International in a deal valued between $5 billion and $5.5bn (around £3.95bn to £4.35bn). If confirmed, this would be the largest-ever overseas acquisition by an Indian pharmaceutical company.
However, Aurobindo issued a statement to stock exchanges denying that any agreement had been finalised.
“As part of our business strategy, the company regularly explores various strategic opportunities, including potential acquisitions and partnerships, which can enhance shareholder value,” Aurobindo Pharma said in a regulatory filing on Wednesday.
“But at present, no binding agreement or definitive decision has been made by the Board of Directors of the company in relation to the transaction referred to in the said article(s). Accordingly, the said news item is premature and should not be relied upon,” the company added.
Aurobindo also assured investors that it would make timely disclosures if any definitive development arises that requires notification under India's regulator, SEBI.
The company's shares fell as much as 4.7 per cent during early trading on Wednesday after the report was published, but recovered slightly following the clarification. The stock closed 3.9 per cent lower on the NSE. So far in 2025, Aurobindo Pharma’s stock has dropped around 21 per cent, compared to a two per cent rise in the benchmark Nifty 50 index.
Advent International and Zentiva have not commented on the report.
Zentiva, based in Prague, is a well-known producer of generic medicines across Europe. If Aurobindo were to go ahead with the acquisition, it would mark a major step in expanding its presence in the European market and diversifying its portfolio beyond the US.
The reported deal would surpass other significant transactions in the Indian pharma sector, including Sun Pharma’s acquisition of Ranbaxy and Biocon Biologics’ buyout of Viatris’ biosimilar business.
Aurobindo is already active in international expansion. In July, its wholly owned US subsidiary signed a deal to acquire Lannett Company LLC, a generics manufacturer, for about $276 million (£218m). That deal is aimed at strengthening its manufacturing base and product offerings in the US.
The US remains a crucial market for Aurobindo, contributing nearly half of its annual revenue. Industry analysts say Indian pharma firms are increasingly pursuing global acquisitions to mitigate risks from potential US trade policies. US president Donald Trump had recently suggested steep tariffs on imported medicines.
“We’ll be putting initially a small tariff on pharmaceuticals, but in one year – one and a half years, maximum – it’s going to go to 150 per cent and then it’s going to go to 250 per cent because we want pharmaceuticals made in our country," Trump said in an interview.